HBV Genotype B/C and Response to Lamivudine Therapy: A Systematic Review

Table 2

Characteristics of HBeAg studies included in the meta-analysis.

Author	Year	𝑁	Age	Sex	Genotype B/C	Severity of liver disease	HBeAg
Zou et al. [11]	2007	41	32.1±9.6	85	6/35	CHB	Positive
Song et al. [12]	2005	413	—	—	53/360	CHB	Positive
Kobayashi et al. [15]	2006	487	45.1±13.1	81	38/449	CHB	Positive
Flink et al. [8]	2006	62	34±9.0	69	23/39	CHB	Positive
Pan et al. [9]	2007	53	53±12	57	22/31	CHB	Positive
Piratvisuth et al. [10]	2008	99	—	—	33/66	CHB	Positive
Chen et al. [13]	2008	45	30±10.7	76	21/24	CHB	Positive
Selabe et al. [14]	2009	6	45±12.6	83	4/2	CHB	Positive
Chien et al. [16]	2003	82	33.8±11.1	77	62/20	CHB	Positive

𝑁: numbers of patients; CHB: chronic hepatitis B.